Governmental influences on drug development: striking a better balance
Miller, Henry I.
Henderson, David R.
MetadataShow full item record
There is currently considerable debate in many countries over the effects of public policy — in particular, governmental regulation — on the development of innovative pharmaceuticals. Regulators must balance patients’ access to therapies with ensuring the safety of drugs. The consequences of poor decisions can be dire: if access is promoted at the expense of safety, a dangerous product can cause incalculable harm; conversely, if safety is over-emphasized at the expense of access, patients can suffer from the absence of life-saving and life- enhancing medications. Using the United States as an example, we discuss the influence of governmental bodies such as the US Food and Drug Administration (FDA), as well as recent legislative initiatives, on pharmaceutical innovation. We argue for a balanced approach to governmental interventions.
The article of record as published may be found at https://doi.org/0.1038/nrd2323
RightsThis publication is a work of the U.S. Government as defined in Title 17, United States Code, Section 101. Copyright protection is not available for this work in the United States.
Showing items related by title, author, creator and subject.
Kitt, John J. (Monterey, California. Naval Postgraduate School, 2006-12);For newly formed democracies, security-sector reform is essential and plays a crucial role in their long-term governmental and institutional stability. The implementation of appropriate security-sector reform by transitional ...
Bodzin, Martin Bradley (1988-09);Credit grantors and employers have two clearly established methods-- judgmental and empirically derived--of determining personal financial responsibility that can be used as a basis for accepting or rejecting credit or ...
Arvay, Randall J. (Monterey, California: Naval Postgraduate School, 2014-06);Information sharing can result in emergent behaviors that affect the safety properties associated with overt information flows. Secure cross-domain integration, involving the safety properties of both individual domains ...